WE@HealthTech
Gal Waingold is an experienced legal professional currently serving as a Committee Member for the Corporate Counsel Committee at the Israel Bar Association since September 2024. Waingold has held the position of Head of Legal for GSK Israel & PNA, overseeing the legal functions of both the Pharma and Consumer Health units since August 2013. Waingold’s extensive experience includes establishing and leading the in-house legal department at GSK, managing various legal aspects such as business development, litigation, privacy, and competition law. Prior experience includes being a Senior Lawyer at S. Horowitz & Co., specializing in commercial dispute resolution and class actions, and an intern at the Supreme Court of Israel. Waingold holds a Master of Laws from Harvard Law School and multiple degrees from Tel Aviv University in law and philosophy.
This person is not in the org chart
WE@HealthTech
Women comprise about 70% of the HealthTech industry work force. Out of the 30 companies listed in the Biomed Index there are only two women CEOs amongst a total of sixty CEOs and Chairmen. The share value of companies that include women on their boards are higher by an average of 44% (Goldman Sachs). FORTUNE 500 companies with a larger number of women in senior management positions have better financial results (Catalyst). It follows that proper representation of women in top managerial levels will serve not only social and gender equality goals, but also organizational, business, and economic goals and performance. In partnership with 8400 we introduce a HealthTech launchpad program to promote junior women managers to executive positions throughout the ecosystem.